3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
2
Conditions
Breast Neoplasms
17
Neoplasm Metastasis
8
Carcinoma, Non-Small-Cell Lung
6
Glioblastoma
5
Triple Negative Breast Neoplasms
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Colorectal Neoplasms
4
Recurrence
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
3
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumors
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Hereditary Sensory and Autonomic Neuropathies
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Brain Neoplasms
2
Waldenstrom Macroglobulinemia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Tongue Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pre-menopausal Breast Cancer
1
Interventions
Cisplatin
150
Radiotherapy
121
Cetuximab
96
Docetaxel
60
Fluorouracil
56
Paclitaxel
45
Radiotherapy, Intensity-Modulated
41
Carboplatin
40
pembrolizumab
34
Surveys and Questionnaires
22
Erlotinib Hydrochloride
19
Nivolumab
18
Immunohistochemistry
16
Gefitinib
16
Drug Therapy
16
Gemcitabine
14
Pemetrexed
13
Gene Expression Profiling
13
durvalumab
12
Chemotherapy, Adjuvant
12
Radiation
11
Filgrastim
11
Bevacizumab
11
Surgical Procedures, Operative
10
Polymerase Chain Reaction
10
Amifostine
10
Celecoxib
9
Capecitabine
9
Standard of Care
8
Neoadjuvant Therapy
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Head and Neck Neoplasms
×
NVP-BKM120
×
Clear all
NCT04338399
2025-11-17
BURAN
Adlai Nortye Biopharma Co., Ltd.
Phase 3
Completed
487 enrolled
NCT01737450
2019-06-24
PIK-ORL
Centre Leon Berard
Phase 2
Completed
58 enrolled